Terms: = Liver cancer AND FANCA, MGC75158, 2175, ENSG00000187741, FA-H, FA, FAA, FANCH, FA1, FACA AND Prognosis
26 results:
1. Fanconi Anemia Complementary Group A (fanca) Facilitates the Occurrence and Progression of liver Hepatocellular Carcinoma.
Huang FD; Zhong YP; Sun GY; Xu QJ; Xing ZY; Chen KH; Liao LS; Dong MY
Dig Dis Sci; 2024 Mar; 69(3):1035-1054. PubMed ID: 38282187
[TBL] [Abstract] [Full Text] [Related]
2. ncRNA-mediated fatty acid metabolism reprogramming in HCC.
Xu K; Xia P; Chen X; Ma W; Yuan Y
Trends Endocrinol Metab; 2023 May; 34(5):278-291. PubMed ID: 36890041
[TBL] [Abstract] [Full Text] [Related]
3. A subset of VEGFR-TKIs activates AMPK in LKB1-mutant lung cancer.
Yang L; Zhang Q; Xiong Y; Dang Z; Xiao H; Chen Q; Dai X; Zhang L; Zhu J; Wang D; Li M
Cancer Sci; 2023 Apr; 114(4):1651-1662. PubMed ID: 36459496
[TBL] [Abstract] [Full Text] [Related]
4. Identification and validation of a fatty acid metabolism-related lncRNA signature as a predictor for prognosis and immunotherapy in patients with liver cancer.
Chen E; Yi J; Jiang J; Zou Z; Mo Y; Ren Q; Lin Z; Lu Y; Zhang J; Liu J
BMC Cancer; 2022 Oct; 22(1):1037. PubMed ID: 36195833
[TBL] [Abstract] [Full Text] [Related]
5. Retrospective analysis of hepatic perivascular epithelioid cell tumour (PEComa) in a single centre for clinical diagnosis and treatment clinical diagnosis and treatment of hepatic PEComa.
Yang X; Wang Q; Zhou X; Zhou H; Jia W; Hu C; Chu J; Kong L
Medicine (Baltimore); 2022 Jun; 101(25):e29506. PubMed ID: 35758391
[TBL] [Abstract] [Full Text] [Related]
6. Comprehensive analysis to identify noncoding RNAs mediated upregulation of maternal embryonic leucine zipper kinase (MELK) correlated with poor prognosis in hepatocellular carcinoma.
Guo Z; Zhu Z
Aging (Albany NY); 2022 May; 14(9):3973-3988. PubMed ID: 35511171
[TBL] [Abstract] [Full Text] [Related]
7. Contrast-enhanced magnetic resonance imaging perfusion can predict microvascular invasion in patients with hepatocellular carcinoma (between 1 and 5 cm).
Wu L; Yang C; Halim A; Rao S; Xu P; Feng W; Chen C; Ji Y; Zhu J; Zeng M
Abdom Radiol (NY); 2022 Sep; 47(9):3264-3275. PubMed ID: 35113174
[TBL] [Abstract] [Full Text] [Related]
8. Cholangiocarcinoma progression depends on the uptake and metabolization of extracellular lipids.
Ruiz de Gauna M; Biancaniello F; González-Romero F; Rodrigues PM; Lapitz A; Gómez-Santos B; Olaizola P; Di Matteo S; Aurrekoetxea I; Labiano I; Nieva-Zuluaga A; Benito-Vicente A; Perugorria MJ; Apodaka-Biguri M; Paiva NA; Sáenz de Urturi D; Buqué X; Delgado I; Martín C; Azkargorta M; Elortza F; Calvisi DF; Andersen JB; Alvaro D; Cardinale V; Bujanda L; Banales JM; Aspichueta P
Hepatology; 2022 Dec; 76(6):1617-1633. PubMed ID: 35030285
[TBL] [Abstract] [Full Text] [Related]
9. Fanconi Anemia Complementation Group E, a DNA Repair-Related Gene, Is a Potential Marker of Poor prognosis in Hepatocellular Carcinoma.
Takahashi J; Masuda T; Kitagawa A; Tobo T; Nakano Y; Abe T; Ando Y; Kosai K; Kobayashi Y; Matsumoto Y; Yoshizumi T; Mori M; Mimori K
Oncology; 2022; 100(2):101-113. PubMed ID: 34724663
[TBL] [Abstract] [Full Text] [Related]
10. Application of Abdominal Imaging Based on Nano Drug Delivery System for Diagnosis and Treatment of liver cancer.
Fan Z; Liu Q; Lu F; Dong Z; Gao P
J Nanosci Nanotechnol; 2021 Feb; 21(2):824-832. PubMed ID: 33183413
[TBL] [Abstract] [Full Text] [Related]
11. Construction of a lipid metabolism-related and immune-associated prognostic signature for hepatocellular carcinoma.
Hu B; Yang XB; Sang XT
Cancer Med; 2020 Oct; 9(20):7646-7662. PubMed ID: 32813933
[TBL] [Abstract] [Full Text] [Related]
12. Aberrant lipid metabolism in hepatocellular carcinoma cells as well as immune microenvironment: A review.
Hu B; Lin JZ; Yang XB; Sang XT
Cell Prolif; 2020 Mar; 53(3):e12772. PubMed ID: 32003505
[TBL] [Abstract] [Full Text] [Related]
13. GRP94 Is Involved in the Lipid Phenotype of Brain Metastatic Cells.
Santana-Codina N; Marcé-Grau A; Muixí L; Nieva C; Marro M; Sebastián D; Muñoz JP; Zorzano A; Sierra A
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31395819
[TBL] [Abstract] [Full Text] [Related]
14. Folic acid-nanoscale gadolinium-porphyrin metal-organic frameworks: fluorescence and magnetic resonance dual-modality imaging and photodynamic therapy in hepatocellular carcinoma.
Chen Y; Liu W; Shang Y; Cao P; Cui J; Li Z; Yin X; Li Y
Int J Nanomedicine; 2019; 14():57-74. PubMed ID: 30587985
[TBL] [Abstract] [Full Text] [Related]
15. Targeting PRPK Function Blocks Colon cancer Metastasis.
Zykova T; Zhu F; Wang L; Li H; Lim DY; Yao K; Roh E; Yoon SP; Kim HG; Bae KB; Wen W; Shin SH; Nadas J; Li Y; Ma W; Bode AM; Dong Z
Mol Cancer Ther; 2018 May; 17(5):1101-1113. PubMed ID: 29483219
[TBL] [Abstract] [Full Text] [Related]
16. New insights into diagnosis and therapeutic options for proliferative hepatoblastoma.
Hooks KB; Audoux J; Fazli H; Lesjean S; Ernault T; Dugot-Senant N; Leste-Lasserre T; Hagedorn M; Rousseau B; Danet C; Branchereau S; Brugières L; Taque S; Guettier C; Fabre M; Rullier A; Buendia MA; Commes T; Grosset CF; Raymond AA
Hepatology; 2018 Jul; 68(1):89-102. PubMed ID: 29152775
[TBL] [Abstract] [Full Text] [Related]
17. Monoacylglycerol Lipase: A Novel Potential Therapeutic Target and Prognostic Indicator for Hepatocellular Carcinoma.
Zhang J; Liu Z; Lian Z; Liao R; Chen Y; Qin Y; Wang J; Jiang Q; Wang X; Gong J
Sci Rep; 2016 Oct; 6():35784. PubMed ID: 27767105
[TBL] [Abstract] [Full Text] [Related]
18. Both de novo synthetized and exogenous fatty acids support the growth of hepatocellular carcinoma cells.
Cao D; Song X; Che L; Li X; Pilo MG; Vidili G; Porcu A; Solinas A; Cigliano A; Pes GM; Ribback S; Dombrowski F; Chen X; Li L; Calvisi DF
Liver Int; 2017 Jan; 37(1):80-89. PubMed ID: 27264722
[TBL] [Abstract] [Full Text] [Related]
19. Acetyl-coenzyme A carboxylase alpha promotion of glucose-mediated fatty acid synthesis enhances survival of hepatocellular carcinoma in mice and patients.
Wang MD; Wu H; Fu GB; Zhang HL; Zhou X; Tang L; Dong LW; Qin CJ; Huang S; Zhao LH; Zeng M; Wu MC; Yan HX; Wang HY
Hepatology; 2016 Apr; 63(4):1272-86. PubMed ID: 26698170
[TBL] [Abstract] [Full Text] [Related]
20. [Multimodal therapy for colon cancer: state of the art].
Weber T; Link KH
Zentralbl Chir; 2011 Aug; 136(4):325-33. PubMed ID: 21863510
[TBL] [Abstract] [Full Text] [Related]
[Next]
